McAfee Paul C, Cappuccino Andrew, Cunningham Bryan W, Devine John G, Phillips Frank M, Regan John J, Albert Todd J, Ahrens Jeanette E
St. Joseph Medical Center, Scoliosis and Spine Center, Baltimore, MD 21204, USA.
J Spinal Disord Tech. 2010 Feb;23(1):1-8. doi: 10.1097/BSD.0b013e31819e2ab8.
The current study of 251 consecutive 1-level anterior cervical reconstructions was undertaken to compare the incidence of dysphagia between cervical disk replacement and conventional anterior cervical fusion and instrumentation.
This is a report of 251 patients from 5 investigational centers in the Food and drug Administration's prospective, randomized porous-coated motion (PCM) trial using a validated dysphagia outcomes instrument. The dysphagia data for both PCM and anterior cervical diskectomy and fusion (ACDF) patients were reviewed from 5 centers to (1) compare the severity of dysphagia, (2) compare the postoperative incidence of dysphagia, and (3) to compare the resolution of perioperative dysphagia.
Dysphagia and dysphonia after anterior surgical approaches to the cervical spine have been previously reported. The current prospective, randomized investigation quantifies clinical dysphagia based on 3 criteria-severity, incidence, and resolution-in a time-course evaluation.
Patients between 18 and 65 years with 1-level symptomatic cervical radiculopathy and/or myelopathy for progressive neurologic symptoms, were randomized to undergo anterior decompression and PCM arthroplasty (N=151) or ACDF (control) (N=100). Patients self-reported dysphagia severity using the Bazaz scale preoperatively and at follow-up. The Bazaz scale has 4 classes of severity based upon the problems with swallowing that the patient has with both liquids and solids.
The Bazaz results demonstrate that although both the PCM and ACDF groups exhibited an initial postoperative problem with swallowing, the PCM group continued to improve with increasing time after implantation, whereas the ACDF only improved minimally. The PCM treatments indicated significantly lower incidence of dysphagia at 3 and 12 months postoperatively compared with ACDF controls (P<0.05). An increase in dysphagia severity at either the 6-week or 3-month follow-up visit was reported in 35 (42%) PCM and 29 (64%) ACDF subjects. Long-term resolution of these symptoms was noted in 74% (26/35) of the PCM subjects as compared with 41.4% (12/29) of the ACDF subjects (P=0.015).
In a prospective randomized clinical study the incidence of postoperative dysphagia and the long-term resolution of the dysphagia was greatly improved in the PCM group compared with the instrumented ACDF control group.
本研究对连续251例单节段颈椎前路重建手术进行了分析,比较颈椎间盘置换术与传统颈椎前路融合内固定术吞咽困难的发生率。
这是一份来自美国食品药品监督管理局前瞻性随机多孔涂层活动(PCM)试验中5个研究中心的251例患者的报告,使用了经过验证的吞咽困难结果评估工具。对PCM组和颈椎前路椎间盘切除融合术(ACDF)组患者的吞咽困难数据进行了回顾,以(1)比较吞咽困难的严重程度,(2)比较术后吞咽困难的发生率,以及(3)比较围手术期吞咽困难的缓解情况。
先前已有报道颈椎前路手术后出现吞咽困难和发音障碍。当前这项前瞻性随机研究在时间进程评估中,基于严重程度、发生率和缓解情况这三个标准对临床吞咽困难进行了量化。
年龄在18至65岁之间、患有单节段症状性神经根型颈椎病和/或脊髓型颈椎病且有进行性神经症状的患者,被随机分为接受前路减压和PCM人工关节置换术(N = 151)或ACDF(对照组)(N = 100)。患者在术前和随访时使用Bazaz量表自我报告吞咽困难的严重程度。Bazaz量表根据患者在吞咽液体和固体时的问题分为4类严重程度。
Bazaz研究结果表明,虽然PCM组和ACDF组术后初期均存在吞咽问题,但PCM组在植入后随着时间推移持续改善,而ACDF组仅略有改善。与ACDF对照组相比,PCM治疗组术后3个月和12个月吞咽困难的发生率显著更低(P < 0.05)。在6周或3个月随访时,35例(42%)PCM组患者和29例(64%)ACDF组患者报告吞咽困难严重程度增加。PCM组中74%(26/35)的患者这些症状得到长期缓解,而ACDF组为41.4%(12/29)(P = 0.015)。
在一项前瞻性随机临床研究中,与ACDF内固定对照组相比,PCM组术后吞咽困难的发生率和吞咽困难的长期缓解情况有显著改善。